OCAT Insider Trading Activity and SEC Form 4 Filings
OCAT insider trading summary
No open-market insider purchases or sales of Ocata Therapeutics, Inc. (OCAT) have been reported on SEC Form 4 in the past 12 months.
Latest OCAT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 10, 2015 | Robert Lanza | Chief Scientific Officer | Sell | $124K (15,000 @ $8.25) |
| Nov 10, 2015 | Robert Lanza | Chief Scientific Officer | Sell | $84K (10,000 @ $8.36) |
| Nov 10, 2015 | Robert Lanza | Chief Scientific Officer | Sell | $84K (10,000 @ $8.36) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.